Intratracheal instillation of polyethylene particles reveals greater lung toxicity in female rats, indicating health risks from pollution.
Micro- and nano-sized polyethylene plastics (PE-MPs and PE-NPs) are emerging as potential risk factors for pulmonary disease and risk assessment. This study aimed to characterize the toxicity of PE-MPs and PE-NPs after 13 wk of intratracheal instillation in Sprague-Dawley (SD) rats and to assess the reversibility of any effects during a 4-week recovery period. Exposure levels for PE-MPs and PE-NPs were set at 0, 40, 80, and 120 μg per head once a week. The results indicated that the treatment administration resulted in observable lung alterations. Inflammatory cells were present in the perivascular and peribronchiolar regions in both sexes at ≥40 μg per head in the PE-MPs and PE-NPs-treated groups, indicating a toxicological change. Additionally, thickened alveolar ducts and alveolar epithelial hyperplasia were noted in males at 120 μg per head PE-MPs, in males at ≥80 μg per head PE-NPs, and in females at ≥40 μg per head PE-MPs and PE-NPs-treated groups. Interestingly, when instilled repeatedly with both sizes of polyethylene particles, IL-1β and TNF-α secretion was significantly enhanced in female rats compared to male rats. At the same time, the pulmonary level of IL-6 increased more clearly in male rats than in female rats. The pulmonary level of C-reactive protein, a marker for acute inflammation, was increased in all treated groups. These findings suggest that the no-observed-adverse-effect level (NOAEL) for PE-MPs and PE-NPs is below 40 μg per head for both sexes. However, the toxicological data for PE-MPs and PE-NPs remain insufficient to confirm their safety, and further research is necessary to evaluate their potential risks to human health.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: